0001512848-20-000003.txt : 20200205
0001512848-20-000003.hdr.sgml : 20200205
20200205153447
ACCESSION NUMBER: 0001512848-20-000003
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
EFFECTIVENESS DATE: 20200205
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCH VENTURE CORP
CENTRAL INDEX KEY: 0001274403
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19358
FILM NUMBER: 20578556
BUSINESS ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001274403
XXXXXXXX
12-31-2019
12-31-2019
ARCH VENTURE CORP
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO
IL
60631
13F HOLDINGS REPORT
028-19358
N
Mark McDonnell
Managing Director, CFO and CAO
773-380-6600
/s/ Mark McDonnell
Chicago
IL
02-05-2020
0
5
76733
false
INFORMATION TABLE
2
ARCH.xml
ADESTO TECHNOLOGIES CORP.
COM
00687D101
17438
2051511
SH
SOLE
0
0
2051511
CHIASMA INC
COM
16706W102
5936
1196776
SH
SOLE
0
0
1196776
KURA ONCOLOGY INC
COM
50127T109
5587
406307
SH
SOLE
0
0
406307
RUBIUS THERAPEUTICS INC
COM
78116T103
24874
2618351
SH
SOLE
0
0
2618351
SYROS PHARMACEUTICALS INC
COM
87184Q107
22898
3313817
SH
SOLE
0
0
3313817